Other Therapeutic Areas

Judi by AG Mednet has revolutionized the clinical trial landscape, bringing unmatched efficiency and reliability to over 13,000 sites spanning 177 countries. Since our inception, AG Mednet has been at the forefront of innovation, deploying cutting-edge solutions designed to support a myriad of trials across various therapeutic areas. Our platform processes millions of images, source documents, and workflows each month, demonstrating our unwavering commitment to advancing medical research and patient care.

Judi's suite of solutions has been instrumental in optimizing studies aimed at discovering new treatments for an extensive array of conditions including rare diseases, cardiometabolic diseases, respiratory illnesses, oncology, endocrinology, gynecology, hematology, immunology, infectious diseases, pulmonary issues, and psychiatric studies, alongside many others within the clinical trial ecosystem.

At the heart of our operations lies a profound dedication to patient centricity, a principle that drives us to promote health equity and bolster scientific discovery. Judi for Eligibility exemplifies this commitment. Designed as a powerful solution for evaluating and maintaining eligibility criteria, especially in support of time-intensive cancer treatments, it enables clinical teams to uphold health equity, thereby ensuring that trials are as inclusive and effective as possible. This tool is frequently used in conjunction with Judi for DSMB, offering globally compliant data collection and transport, role-based viewing restrictions for DMC and DSMB members, and a comprehensive audit trail to guarantee trial safety.

Furthermore, recognizing the critical role of training and qualification in conducting seamless trials, Judi for Site and User Qualification has been developed to streamline, qualify, and monitor remote eClinical training in real-time. This ensures that all involved parties are adequately prepared and informed, enhancing the overall trial process. And Judi for Monitoring seamlessly integrates essential workflows, robust security protocols, and comprehensive de-identification practices alongside HIPAA/GDPR compliance measures, catering to the most demanding requirements set forth by global privacy regulations.

In clinical research, where precision and reliability are paramount, Judi for Imaging stands out as the industry leader for DICOM image management. This solution facilitates the secure upload, storage, and retrieval of clinical data, offering an indispensable resource for trials. When paired with Judi for Adjudication, it provides a robust platform for endpoint adjudication workflow management, utilized extensively by CROs and sponsors in oncology trials. Together, these solutions significantly reduce time and expense while ensuring the integrity of trials.

AG Mednet’s Judi platform is a testament to our commitment to innovation, offering an all-encompassing solution for the clinical trial ecosystem. With features such as compliant e-signatures on all eCRFs, real-time oversight, and visibility into trial data, our platform is designed to instill confidence in our users. Its compliance with HIPAA, GDPR, and 21 CFR Part 11, coupled with SOC2T2 certification, ensures the highest standards of data security and privacy. Moreover, its AWS-enabled and intuitive user-based interface, along with the ability to generate key reports and dashboards, makes it fully adaptable to your process/SOPs, offering a seamless and efficient trial management experience.

As we continue to expand our presence and influence in the clinical trial domain, Judi by AG Mednet remains dedicated to delivering solutions that not only meet but exceed the expectations of our users, driving forward the pursuit of breakthrough treatments and innovations in healthcare.

Other Therapeutic Areas
Other Therapeutic Areas

Judi is transforming global clinical development across 20 therapeutic areas and countless indications.

Rare Disease
Rare Disease

From Pediatric Sickle Cell to Mitochondrial Disease, Rare Disease research is powered by Judi

Cardiometabolic
Cardiometabolic

The escalating prevalence of cardiometabolic diseases significantly underscores their importance in the realm of global clinical trials.

Oncology
Oncology

Supporting 5,200 patient eligibility determinations across 900 Oncology trials in every phase